Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate + Loratadine in Seasonal Allergic Rhinitis
NCT03855228Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 1995
- Primary completion
- Aug 1995
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Organon & Co. Primary endpoints: Total Nasal Symptom Score at 15 days and Total Symptom Score at 15 days. Started Mar 1995; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03855228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03855228.